Ropes Wealth Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $380K | Hold |
9,212
| – | – | 0.07% | 186 |
|
|
2023
Q2 | $514K | Buy |
9,212
+2,395
| +35% | +$134K | 0.09% | 170 |
|
|
2023
Q1 | $380K | Sell |
6,817
-2,954
| -30% | -$165K | 0.07% | 197 |
|
|
2022
Q4 | $356K | Hold |
9,771
| – | – | 0.06% | 200 |
|
|
2022
Q3 | $278K | Sell |
9,771
-132
| -1% | -$3.76K | 0.06% | 202 |
|
|
2022
Q2 | $448K | Hold |
9,903
| – | – | 0.09% | 181 |
|
|
2022
Q1 | $753K | Hold |
9,903
| – | – | 0.13% | 146 |
|
|
2021
Q4 | $1.48M | Buy |
9,903
+132
| +1% | +$19.7K | 0.26% | 87 |
|
|
2021
Q3 | $1.42M | Buy |
9,771
+554
| +6% | +$80.6K | 0.23% | 92 |
|
|
2021
Q2 | $1.81M | Sell |
9,217
-1,455
| -14% | -$285K | 0.29% | 80 |
|
|
2021
Q1 | $1.47M | Buy |
10,672
+5,429
| +104% | +$745K | 0.26% | 90 |
|
|
2020
Q4 | $742K | Buy |
5,243
+2,597
| +98% | +$368K | 0.12% | 121 |
|
|
2020
Q3 | $330K | Buy |
+2,646
| New | +$330K | 0.06% | 167 |
|